Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-15

Clinical Trial Update: Protein for Premies [NA]

View source ↗

Summary

This clinical trial update notes that a study investigating a protein for extreme prematurity has completed. It was sponsored by University Hospital Tuebingen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Extreme Prematurity | NA | Status: COMPLETED